260 related articles for article (PubMed ID: 27842816)
21. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
22. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
23. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
[TBL] [Abstract][Full Text] [Related]
24. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
25. A novel chitosan-citric acid crosslinked beta-cyclodextrin nanocarriers for insoluble drug delivery.
Karpkird T; Manaprasertsak A; Penkitti A; Sinthuvanich C; Singchuwong T; Leepasert T
Carbohydr Res; 2020 Dec; 498():108184. PubMed ID: 33189031
[TBL] [Abstract][Full Text] [Related]
26. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
27. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
[TBL] [Abstract][Full Text] [Related]
29. Permeability Profiles and Intestinal Toxicity Assessment of Hydrochlorothiazide and Its Inclusion Complex with β-Cyclodextrin Loaded into Chitosan Nanoparticles.
Onnainty R; Schenfeld EM; Petiti JP; Longhi MR; Torres A; Quevedo MA; Granero GE
Mol Pharm; 2016 Nov; 13(11):3736-3746. PubMed ID: 27756134
[TBL] [Abstract][Full Text] [Related]
30. Oral insulin delivery by carboxymethyl-β-cyclodextrin-grafted chitosan nanoparticles for improving diabetic treatment.
Song M; Wang H; Chen K; Zhang S; Yu L; Elshazly EH; Ke L; Gong R
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S774-S782. PubMed ID: 30280608
[TBL] [Abstract][Full Text] [Related]
31. Chitosan nanoparticles as adenosine carriers.
Kazemzadeh-Narbat M; Reid M; Brooks MS; Ghanem A
J Microencapsul; 2015; 32(5):460-6. PubMed ID: 26052724
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
Arif M; Raja MA; Zeenat S; Chi Z; Liu C
J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
[TBL] [Abstract][Full Text] [Related]
33. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
34. Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles.
Wu J; Wang Y; Yang H; Liu X; Lu Z
Carbohydr Polym; 2017 Nov; 175():170-177. PubMed ID: 28917853
[TBL] [Abstract][Full Text] [Related]
35. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
Elmoghayer ME; Saleh NM; Abu Hashim II
Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
[TBL] [Abstract][Full Text] [Related]
36. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
[TBL] [Abstract][Full Text] [Related]
37. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
Yu N; Li G; Gao Y; Liu X; Ma S
Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
[TBL] [Abstract][Full Text] [Related]
38. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study.
Jingou J; Shilei H; Weiqi L; Danjun W; Tengfei W; Yi X
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):103-7. PubMed ID: 21112190
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of lysozyme into cellulose nanocrystals stabilized β-chitosan nanoparticles with enhanced antibacterial activity.
Zhang H; Feng M; Chen S; Shi W; Wang X
Carbohydr Polym; 2020 May; 236():115974. PubMed ID: 32172828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
